LONDON: Apax X Fund, in which AGA is a limited partner, has entered into a definitive agreement to acquire a majority stake of Herjavec Group (HG), an award-winning global Managed Security Services Provider (MSSP) and cyber operations leader. The transaction is expected to close in the second quarter of 2021, subject to customary closing conditions. …
InfraStrata plc acquires assets of Burntisland Fabrication Limited
LONDON: InfraStrata plc has acquired substantially all of the assets of Burntisland Fabrication Limited, providing the Company with increased capacity across two sites in prime locations in Scotland. The consideration paid for the assets is £650,000 in cash with a further deferred consideration of up to £200,000 in cash, subject to achievement of future revenues…
Mail.ru, USM, MegaFon, RDIF, Ant Group sign agreements to form joint ventures in payments and financial services
LONDON: Mail.ru Group, USM, Ant Group, Russian Direct Investment Fund (RDIF) and MegaFon announced that they have signed binding agreements to create a payments joint venture (PJV) and a financial services joint venture (FSJV). The announcement follows the signing of non-binding term sheets in 2019, when the parties announced a partnership to promote financial inclusion…
Mutares plans EUR 10mn additional tap issue of its bond issued in February 2020
MUNICH: Mutares SE & Co. has decided today to consider an additional increase of the EUR 70 million bond issued in February 2020 with 4-year maturity by up to EUR 10 million. The Bond had been originally issued in an amount of EUR 50 million with an optional tap issue of EUR 30 million. In…
Valor Resources completes acquisition of uranium asset
SYDNEY: Valor Resources Limited entered into agreements to acquire 100% of the issued capital of Pitchblende Energy Pty Ltd the holder of interests in two uranium projects located in Saskatchewan, Canada. The Transaction was subject to various conditions precedent including shareholder approvals. As announced on 29 January 2021, shareholders approved all the resolutions tabled at…
Valor Resources Limited (ASX:VAL)
Valor Resources Limited (ASX:VAL) is an exploration company focussed on creating shareholder value through acquisitions and exploration activities. The Company is focussed on two key projects as outlined below in Peru and Canada. Valor’s 100% owned Peruvian subsidiary, Kiwanda SAC holds the rights to the Picha & Berenguela South Projects located in the Moquegua Department…
U.S. Energy Corp. plans public offering of common stock
HOUSTON: U.S. Energy Corp. has announced intention to offer its common shares in an underwritten public offering. In connection with the offering, the Company expects to grant the underwriters a 45-day option to purchase an additional 15% of the shares of its common stock offered in the public offering on the same terms and conditions….
Wattle Health acquires remaining 20% of Little Innoscents
SYDNEY: Wattle Health Australia Limited has entered into a Share Sale Agreement (SSA) to acquire the remaining 20% of Little Innoscents (LI) for $200,000, taking the Company’s ownership of LI to 100%. Little Innoscents has established a reputation as a premium brand in the natural and organic skincare sector and has produced growing month-on-month sales,…
urban-gro announces pricing of $54mn public offering and Nasdaq listing
LAFAYETTE: urban-gro Inc. announced the pricing of an underwritten public offering of 5.4 million shares at a public offering price of $10 per share for aggregate gross proceeds of $54 million. In addition, urban-gro has granted the underwriters a 45-day option to purchase up to an additional 810,000 shares of common stock at the public…
Starpharma signs research agreement with MSD
MELBOURNE: Starpharma Holdings has signed a Research Agreement with MSD, the tradename of Merck & Co., Inc., Kenilworth NJ USA. Under the agreement, MSD will conduct a preclinical research evaluation of dendrimer based Antibody Drug Conjugates (ADCs) utilising Starpharma’s proprietary DEP technology. Dr Jackie Fairley, CEO of Starpharma commented: “MSD is a recognised leader in…
Starpharma Holdings Limited (ASX:SPL)
Click Here Starpharma Holdings Limited (ASX:SPL) share price Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP® drug delivery and VivaGel®. Starpharma is developing VIRALEZE™, an antiviral nasal spray for…
Oncorus prices public offering of 3.0 million common shares
CAMBRIDGE: Oncorus Inc. announced the pricing of its underwritten public offering of 3.0 million shares of its common stock at a price to the public of $19 per share. All shares of common stock in the offering are being offered by Oncorus. The gross proceeds to Oncorus from the offering, before deducting underwriting discounts and…